Advertisement
Screener

ENLIVEN THERAPEUTICS, INC. (ELVN) Stock Issued During Period, Value, New Issues

ENLIVEN THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • ENLIVEN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $159.54M.
  • ENLIVEN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $10.47M.
  • ENLIVEN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $66.05M.
  • ENLIVEN THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $159.54M.
  • ENLIVEN THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $76.53M.
Period endStock Issued During Period, Value, New Issues 3 monthStock Issued During Period, Value, New Issues 12 month
2023-12-31$159.54M
10-K · filed 2025-03-13
2023-03-31$159.54M
10-Q · filed 2024-11-13
2020-12-31$76.53M
10-K · filed 2022-03-15
2020-06-30$10.47M
10-Q · filed 2021-08-06
2020-03-31$66.05M
10-Q · filed 2021-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
AbCellera Biologics Inc. (ABCL)$3.879B-14.59